With all the good press, confer yesterday's Times, plus the Wall Street Journal telling the market about the £3m equity draw down in place, this can only be good news!
BUY
Name change allied with being classified as a Health stock in the FT must be worth further investment, in fact my earlier broker's note target of 30p looks a steal.
Pile in there boys because I will!
There are brokers indicating a target buy of just under 30p so I feel there a strong case for a long term buy on top of directors filling their boots so as they say on Dragon's Den I'm in...........